Pelvic inflammatory disease

Obstetrics and Gynecology

Volumn 116, Issue 2 PART 1, 2010, Pages 419-428

  Soper, David E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; METRONIDAZOLE; PROBENECID; SULTAMICILLIN;

BLEEDING; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DIFFERENTIAL DIAGNOSIS; ECTOPIC PREGNANCY; FEVER; GENITAL TRACT INFLAMMATION; GRAM NEGATIVE AEROBIC RODS AND COCCI; GRAM NEGATIVE ANAEROBIC BACTERIA; HOSPITALIZATION; IMAGING; INFERTILITY; LAPAROSCOPY; METRORRHAGIA; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; OUTPATIENT CARE; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PERITONEAL CAVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; SALPINGITIS; SCREENING; SEXUALLY TRANSMITTED DISEASE; TUBOOVARIAN ABSCESS; URINARY FREQUENCY; UTERINE CERVIX; VAGINA DISCHARGE; VAGINITIS;

FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE;

EID: 77955156393     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181e92c54     Document Type: Review

References (69)

1. Monif GR. Clinical staging of acute bacterial salpingitis and its therapeutic ramifications. Am J Obstet Gynecol 1982;143: 489-495
2. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States 1985-2001. Sex Transm Dis 2005;32:778-784
3. Rein DB, Kassler WJ, Irwin KL, Rabiee L. Direct medical cost of pelvic inflammatory disease and its sequelae: decreasing, but still substantial. Obstet Gynecol 2000;95:397-402.
4. Patton DL, Moore DE, Spadoni LR, Soules MR, Halbert SA, Wang SP. A comparison of the fallopian tube's response to overt and silent salpingitis. Obstet Gynecol 1989;73:622-630
5. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008;135: 739-749
6. Sweet RL, Draper DL, Schachter J, James J, Hadley WK, Brooks GF. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol 1980;138:985-989
7. Soper DE, Brockwell NJ, Dalton HP, Johnson D. Microbial etiology of urban emergency department acute salpingitis: treatment with ofloxacin. Am J Obstet Gynecol 1992;167: 653-660
8. Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994;170:1008-1014
9. McGregor JA, French JI, Jones W, Milligan K, McKinney PJ, Patterson E, Parker R. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-1059
10. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000;183:1243-1248
11. Paavonen J, Critchlow CW, DeRouen T, Stevens CE, Kiviat N, Brunham RC, et al. Etiology of cervical inflammation. Am J Obstet Gynecol 1986;154:556-564
12. Hillier SL, Kiviat NB, Hawes SE, Hasselquist MB, Wolner Hanssen P, et al. Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 1996;175: 435-441
13. Eschenbach DA, Buchanan TM, Pollack HM, Forsyth PS, Alexander ER, Lin JS, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975;293: 166-171
14. Sweet RL. Treatment strategies for pelvic inflammatory disease. Expert Opin Pharacother 2009;10:823-837
15. Haggerty CL, Totten PA, Astete SG, Ness RB. Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. Infect Dis Obstet Gynecol 2006; 2006:30184.
16. Cohen CR, Mugo NR, Astete SG, Odondo R, Manhart LE, Kiehlbach JA, et al. Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis. Sex Transm Infect 2005;81:463-466
17. Short VL, Totten PA, Ness RB, Astet SG, Kelsey SF, Haggerty CL. Clinical presentation of Mycoplasma genitalium infection versus Neisseria gonorrhoeoe infection among women with pelvic inflammatory disease. Clin Infect Dis 2009;48:41-47
18. Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility. A cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-192
19. Patton DL. Immunopathology and histopathology of experimental chlamydial salpingitis. Rev Infect Dis 1985;7: 746-753
20. Soper DE. Diagnosis and laparoscopic grading of acute salpin-gitis. Am J Obstet Gynecol 1991;164(5 Pt 2):1370-1376
21. Simms I, Warburton F, Westrom L. Diagnosis of pelvic inflammatory disease: time for a rethink. Sex Transm Infect 2003;79:491-494
22. Wiesenfeld HC, Hillier SL, Krohn MA, Amortegui AJ, Heine RP, Landers DV, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100:456-463
23. Eckert LO, Hawes SE, Wolner-Anssen PK, Kiviat NB, Wasserheit JN, Paavonen JA, et al. Endometritis: the clinical-pathologic syndrome. Am J Obstet Gynecol 2002;186: 690-695
24. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amotegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005;32:400-405
25. Wolner-Hanssen P, Mardh PA, Svensson L, Westrom L. Laparoscopy in women with chlamydial infection and pelvic pain: a comparison of patients with and without salpingitis. Obstet Gynecol 1983;61:299-303.
26. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA 1991;266:2594-2604
27. Jacobson L, Westrom L. Objectivized diagnosis of acute pelvic inflammatory disease. Diagnostic and prognostice value of routine laparoscopy. Am J Obstet Gynecol 1969; 105:1088-1098
28. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2006:55(RR-11):1-94. Erratum in: MMWR Recomm Rep 2006;55:997.
29. Johnson AM, Wadsworth J, Wellings K, Field J. Sexual attitudes and lifestyles. Oxford (UK): Blackwell Scientific Publications; 1994.
30. Brunham RC, Paavonen J, Stevens CE, Kiviat N, Kuo C-C, Critchlow CW, et al. Mucopurulent cervicitis\the ignored counterpart in women of urethritis in men. N Engl J Med 1984;311:1-6.
31. Yudin MH, Hillier SL, Wiesenfeld HC, Krohn MA, Amor-tegui AA, Sweet RL. Vaginal polymorphonuclear leukocytes and bacterial vaginosis as markers for histologic endometritis among women without symptoms of pelvic inflammatory disease. Am J Obstet Gynecol 2003;188: 318-323
32. Gaitan H, Angel E, Diaz R, Parada A, Sanchez L, Vargas C. Accuracy of five different diagnostic techniques in mild-to-moderate pelvic inflammatory disease. Infect Dis Obstet Gynecol 2002;10:171-180
33. Cacciatore B, Leminen A, Ingman-Friberg S, Ylostalo P, Paavonen J. Transvaginal sonographic findings in ambulatory patients with suspected pelvic inflammatory disease. Obstet Gynecol 1992;80:912-916
34. Rao PM, Rhea JT, Novelline RA, Mostafavi AA, McCabe CJ. Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med 1998;338:141-146
35. Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151:1098-1110
36. Eckert LO, Thwin SS, Hillier SL, Kiviat NB, Eschenbach DA. The antimicrobial treatment of subacute endometritis: a proof of concept study. Am J Obstet Gynecol 2004;190: 305-313
37. Walker CK, Workowski KA, Washington AE, Soper DE, Sweet RL. Anaerobes in pelvic inflammatory disease: implications for the Centers For Disease Control And Prevention's guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999;28(suppl 1):S29-36.
38. Haggerty CL, Totten PA, Astete SG, Lee S, Hoferka SL, Kelsey SF, et al. Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. Sex Transm Infect 2008;84:338-342
39. Crombleholme WR, Schachter J, Ohm-Smith M, Luft J, Whid-den R, Sweet RL. Efficacy of single-agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxa-cin. Am J Med 1989;87:142S-7S.
40. Martens MG, Gordon S, Yarborough DR, Faro S, Binder D, Berkeley A. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group. South Med J 1993;86:604-610
41. Ross JD, Cronje HS, Paszkowski T, Rakoczi I, Vildaite D, Kureishi A, et al. Moxifloxacin versus ofloxacin plus metroni-dazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomized trial. Sex Transm Infect 2006;82:446-451
42. Centers for Disease Control and Prevention. Update to CDC's sexually transmitted diseases treatment guidelines 2006: fluo-roquinolones no longer recommended for the treatment of gonococcal infections. MMWR Recomm Rep 2007;56(RR-14):332-336
43. Eschenbach D. Treatment of pelvic inflammatory disease. Clin Infect Dis 2007;44:961-963
44. Haggerty CL, Ness RB. Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. Expert Rev Anti Infect Ther 2006;4:235-247
45. Goldstein EJ, Nesbit CA, Citron DM. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxa-cin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates. Antimicrob Agents Che-mother 1995;39:1097-1100
46. Merriam CV, Citron DM, Tyrrell KL, Warren YA, Goldstein EJ. In vitro activity of azithromycin and nine comparator agents against 296 strains of oral anaerobes and 31 strains of Eikenella corrodens. IntJ Antimicrob Agents 2006;28:244-248
47. Taylor-Robinson D, Bebear C. Antibiotic susceptibilities of mycoplasmas and treatment of mycoplasmal infections. J Antimicrob Chemother 1997;40:622-630
48. Taylor-Robinson D. Mycoplasma genitalium-an up-date. Int J STD AIDS 2002;13:145-151
49. Patton DL, Sweeney YT, Stamm WE. Significant reduction in inflammatory response in the macaque model of chlamydia pelvic inflammatory disease with azithromycin treatment. JID 2005;192:129-135
50. Malhotra M, SharmaJB, Batra S, Arora R, Sharma S. Cipro-floxacin- tinidazole combination, fluconazole-azithromycin-secnidazole-kit and doxycycline-metronidazole combination therapy in syndromic management of pelvic inflammatory disease: a prospective randomized controlled trial. Indian J Med Sci 2003;57:549-555
51. Bevan CD, Ridgway GL, Rothermel CD. Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease. J Int Med Res 2003;31:45-54.
52. Savaris RF, Teixeira LM, Torres TG, Edelweiss MIA, Moncada J, Schachter J. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease. A randomized controlled trial. Obstet Gynecol 2007; 110:53-60.
53. Sweet RL, Schachter J, Robbie MO. Failure of/3-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 1983;250:2641-2645
54. Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: Results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929-937
55. Schwebke JR, Schulien MB, Zajackowski M. Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect Dis Obstet Gynecol 1995;3:119-122
56. Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tuboovarian abscess. Am J Obstet Gynecol 1985; 151:1098-1110
57. Reed SD, Landers DV, Sweet RL. Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum beta-lac-tam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 1991;164:1556-1562
58. Gilbert DN, Leggett JE. Aminoglycosides. In: Mandel GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia (PA): Churchill Livingstone Elsevier; 2010. p. 367.
59. McNeeley SG, Hendrix SL, Mazzoni MM, Kmak DC, Ransom SB. Medically sound, cost-effective treatment for pelvic inflammatory disease and tuboovarian abscess. AmJ Obstet Gynecol 1998;178:1272-1278
60. Sivapalasingam S, Steigbigel NH. Macrolides, clindamcyin, and ketolides In: Mandel GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. 7th ed. Philadelphia (PA): Churchill Livingstone Elsevier; 2010. page 442.
61. Rivlin ME, HuntJA. Ruptured tuboovarian abscess: is hysterectomy necessary? Obstet Gynecol 1977;50:518-522
62. Wiesenfeld HC, Sweet RL. Progress in the management of tuboovarian abscesses. Clin Obstet Gynecol 1993;36:433-444
63. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707-713
64. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1991;168:1503-1509
65. Lepine LA, Hillis SD, Marchbanks PA, Joesoef MR, Peterson HB, Westrom L. Severity of pelvic inflammatory disease as a predictor of the probability of live birth. Am J Obstet Gynecol 1998;178:977-981
66. Joesoef MR, Westrom L, Reynolds G, Marchbanks P, Cates W. Recurrence of ectopic pregnancy: the role of salpingitis. Am J Obstet Gynecol 1991;165:46-50.
67. Thurman AR, Soper DE. Sequelae In: Sweet RL, Wiesenfeld HC, editors. Pelvic inflammatory disease. Boca Rotan (FL): Taylor & Francis; 2006. p. 69-83.
68. Washington AE, Cates W Jr, Wasserheit JN. Preventing pelvic inflammatory disease. JAMA 1991;266:2574-2580
69. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-1366 (Pubitemid 26152715)